Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07192159 · ClinicalTrials.gov registry record · NA
Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD
A NA study of Metabolic Dysfunction Associated Steatotic Liver Disease and Hepatic Steatosis, sponsored by Seoul National University Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 62
- Enrollment target
- 2
- Study locations
NCT07192159: Recruiting NA study of Metabolic Dysfunction Associated Steatotic Liver Disease and Hepatic Steatosis, sponsored by Seoul National University Hospital.
NCT07192159 is a NA study of Metabolic Dysfunction Associated Steatotic Liver Disease and Hepatic Steatosis that is actively recruiting participants, run by Seoul National University Hospital. The registered enrollment target is 62 participants, below the 731-participant average among 7 other Metabolic Dysfunction Associated Steatotic Liver Disease trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07192159, a NA study of Metabolic Dysfunction Associated Steatotic Liver Disease and Hepatic Steatosis, is actively recruiting participants, sponsored by Seoul National University Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
- 2
- Study locations
Study Summary
This multicenter prospective study aims to evaluate the correlation between quantitative ultrasound fat fraction (USFF) and MRI-PDFF (Proton Density Fat Fraction) for liver fat quantification in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). The study will compare the diagnostic accuracy of quantitative ultrasound imaging against MRI-PDFF as the reference standard.
Primary Outcome
earson correlation coefficient between quantitative ultrasound fat fraction (USFF) and MRI-PDFF
Conditions Studied
Interventions
- DEVICE Quantitative ultrasound (DeepUSFF)
Study Locations (2)
Ohio
- southwoods imaging (Northeastern Ohio Radiology Research and Education Fund ) - Boardman
Seoul
- Seoul National University Hospital - Seoul
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2025-06-24 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT07192159 shows while recruiting
NCT07192159 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 731-participant average among 7 other Metabolic Dysfunction Associated Steatotic Liver Disease trials with a reported enrollment target (92% lower).
The record links to 3 conditions, with Metabolic Dysfunction Associated Steatotic Liver Disease appearing as the primary indexed condition, and to 1 intervention - of which Quantitative ultrasound (DeepUSFF) is the first listed.
NCT07192159 reports a single indexed study location in Ohio, Seoul.
Frequently Asked Questions
What is clinical trial NCT07192159 about?
NCT07192159 is a clinical study titled "Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD". This multicenter prospective study aims to evaluate the correlation between quantitative ultrasound fat fraction (USFF) and MRI-PDFF (Proton Density Fat Fraction) for liver fat quantification in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). The study will compare th...
What is the current status of trial NCT07192159?
This trial is currently recruiting. It is a NA study. The enrollment target is 62 participants. The study started on 2025-06-24. Estimated completion is 2026-06-30.
What conditions does trial NCT07192159 study?
This clinical trial studies the following conditions: Metabolic Dysfunction Associated Steatotic Liver Disease, Hepatic Steatosis, Liver Disease Parenchymal.
What interventions are being tested in trial NCT07192159?
The interventions under investigation include: Quantitative ultrasound (DeepUSFF) (DEVICE).
Who is sponsoring clinical trial NCT07192159?
This trial is sponsored by Seoul National University Hospital, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07192159 being conducted?
This trial has 2 study locations across Ohio, Seoul. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolic Dysfunction Associated Steatotic Liver Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Non-Invasive Diagnostic Tests for MASLD in Pediatric Population
RECRUITING · NA
-
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
RECRUITING · NA
-
Influence of Metabolic Syndrome on Endogenous Oxalate Synthesis
RECRUITING · NA
-
Feasibility of the Paso Program for Patients With Metabolic Dysfunction Associated Steatotic Liver Disease
ACTIVE NOT RECRUITING · NA
-
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
RECRUITING · Phase 3
-
A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI